SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
144 Hello, John. A little of the Syntex story is that they were the darling of WalJohn Metcalf-5/21/1997
143 The market seems to approve of the change to Freiman. NTII stock has incresed oDr. John M. de Castro-5/21/1997
142 Third Quarter Results... biz.yahoo.comdch-5/14/1997
141 Paul Freiman is the guy who took Syntex, with a dry pipeline and facing patent John Metcalf-5/14/1997
140 Rick, this thread is too quiet considering the buying activity we've seen iJohn Wright-5/13/1997
139 Chuckle. Vadim..... I pulled it because I had grown sick of management. Howscaram(o)uche-5/10/1997
138 Richard, have you pulled NTII from the "favorite/undiscovered gems" lVadim D. Marchenko-5/9/1997
137 Sorry about the Cohen - Freiman mixup. I was in a rush when I posted the informDr. John M. de Castro-5/9/1997
136 //NTII just announced the replacement of Jeff Price with Abraham Cohen as PresiHoward Frederick-5/9/1997
135 Thanks for info. I think we will now see some action on this baby.Kenneth E. De Paul-5/8/1997
134 NTII just announced the replacement of Jeff Price with Abraham Cohen as PresideDr. John M. de Castro-5/8/1997
133 I've attached an exerpt from a Bioworld Article regarding NMDA antagonists Dr. John M. de Castro-5/7/1997
132 This is an important development for NTII. Thanks for posting the Phase II NeurDr. John M. de Castro-4/29/1997
131biz.yahoo.comkathleen-4/29/1997
130 This is very good news for NTII. I was wondering how long the Board would put uDr. John M. de Castro-4/28/1997
129biz.yahoo.comkathleen-4/28/1997
128 To insert a link you just type the address of the site. Anything beginning withkathleen-4/24/1997
127 Dea Dr. I hope you don't mind, I took the liberty to insert the link for ySam Quentin-4/23/1997
126 Howard. I posted a response to the rebuttal on the CNSI thread. Tell me how youDr. John M. de Castro-4/23/1997
125 NTII traded over 200,000 shares today. There were major blocks traded. Does aSam Quentin-4/22/1997
124 While browsing around Silicon Investor, I came across this post in the CambridgHoward Frederick-4/22/1997
123 No, but IPIC presented a paper that is good news for both NTII and CNSI. I'Dr. John M. de Castro-4/18/1997
122 Thanks, that was helpful, but not altogther encouraging (I own CNSI, but monitoTheSlowLane-4/18/1997
121 Cambridge Neurosciences (CNSI) is developing Cerestat (aka CNS 1102 or AptiganeDr. John M. de Castro-4/17/1997
120 Price to Mohr........ "Larry, my shoe came untied again. Could you show scaram(o)uche-4/17/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News